Can Coaching and Monitoring Boost GLP-1 Weight Loss?

✓ Medically reviewed | Published: | Evidence level: 1A
A study presented at the HLTH conference by Calibrate and Withings reportedly found that combining GLP-1 medication with wraparound care, such as coaching and connected-device monitoring, increased weight loss by more than 60%. The finding comes from a company-linked analysis and needs independent confirmation, but it fits a broader view that medication works best alongside lifestyle support.
📅 Published:
✓ Reviewed by iMedic Medical Editorial Team
📄 Weight Loss

Quick Facts

Reported Boost
More than 60%
Adults With Obesity
Over 1 billion worldwide
Study Source
Company-linked, HLTH presentation

What is wraparound care for GLP-1 weight loss?

Quick answer: Wraparound care means pairing GLP-1 medication with support such as coaching, nutrition guidance, activity tracking and regular monitoring.

GLP-1 medications such as semaglutide and tirzepatide reduce appetite and can produce substantial weight loss, but the drugs are not a standalone solution. Programs described as wraparound care typically add behavioral coaching, dietary advice, physical activity support and tracking of measures such as weight through connected devices like smart scales.

The approach reflects clinical guidance that has long recommended medications for obesity be used together with lifestyle intervention. The practical goal is to help people preserve muscle, manage side effects such as nausea, maintain adequate protein and fluid intake, and build habits that may help sustain results over time.

How strong is the evidence that added support improves results?

Quick answer: The reported improvement of more than 60% is promising, but it comes from a company-linked analysis and should be confirmed in peer-reviewed, controlled research.

According to Fierce Healthcare's report from the HLTH conference, the Calibrate and Withings analysis found that wraparound care boosted GLP-1 weight loss by more than 60%. Without full details on study design, participants and comparison groups, it is difficult to judge how much of that difference reflects the support itself rather than differences in who enrolls in such programs.

That caveat matters. People who choose structured programs may be more motivated, and real-world analyses can be affected by selection and dropout. Randomized trials remain the strongest way to test whether coaching and monitoring add benefit beyond medication alone.

Even so, the direction of the finding is consistent with the broader literature on obesity treatment, where intensive behavioral support has generally improved outcomes. For patients, the practical takeaway is that medication, nutrition, movement and follow-up work together, and access to that support may shape results as much as the drug itself. The World Health Organization estimates that more than one billion people live with obesity, so scalable models of support are of considerable public health interest.

Frequently Asked Questions

Not required, but clinical guidance generally recommends combining obesity medication with lifestyle support. Coaching may help with nutrition, side effects and long-term habits.

It was reported from a company-linked analysis presented at a conference. It is suggestive, but independent, peer-reviewed confirmation is needed.

Programs commonly include behavioral coaching, nutrition guidance, physical activity support and regular tracking of weight or other health measures.

References

  1. Fierce Healthcare. HLTH 2026: Calibrate, Withings study finds wraparound care boosts GLP-1 weight loss by more than 60%. November 2026.
  2. World Health Organization. Obesity and overweight fact sheet.